Chicago, Jun 3 (EFE).- Adapting breast cancer therapy based on patient response can eliminate the need for chemotherapy in a significant number of treatments that currently default to it, according to a study suggesting that a third of patients can successfully avoid this technique. The phase II PHERGain clinical trial,…Read More
Adaptive breast cancer therapy may bypass chemotherapy for 30 of patients
